SCHEMBL11181706

SCHEMBL11181706

COC(=O)CCC/C=C\C[C@@H]1[C@@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)C[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
HKDC1 Q2TB90 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
SAE1 Q9UBE0 1/20 0.52
UBA2 Q9UBT2 1/20 0.52
PTGER2 P43116 1/20 0.46
CA2 P00918 3/20 0.45
PDE4D Q08499 5/20 0.43
PGR P06401 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADRA2C P18825 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2B P41595 1/20 0.43
MC3R P41968 1/20 0.43
SLC6A3 Q01959 1/20 0.43
SCN5A Q14524 1/20 0.43
PTGFR P43088 3/20 0.39
MAPK1 P28482 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13211811 0.84 KDM4E (0.41) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL13105834 0.84 KDM4E (0.41) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL11912325 0.84 KDM4E (0.41) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL10702946 0.84 KDM4E (0.41) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL13119881 0.84 KDM4E (0.41) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL12363806 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL12363820 0.80 PGR (0.38) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL7671826 0.80 KDM4E (0.38) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL7671832 0.80 KDM4E (0.38) ALDH1A1KDM4EHKDC1TDP1SAE1
SCHEMBL7671839 0.80 KDM4E (0.38) ALDH1A1KDM4EHKDC1TDP1SAE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4378370-A Certain 5-cyano-16-fluoro-prostacyclins and their use as pharmaceuticals SCHERING AKTIENGESELLSCHAFT (DE) 1983-03-29 US disclosed